David Luther joined Mission Therapeutics in 2015 as the Chief Financial Officer.
Mr. Luther brings more than 25 years of financial and operational experience, across the pharmaceutical and Fast Moving Consumer Goods (FMCG) industries.
Prior to joining Mission Therapeutics, David worked as VP Finance in the UK, Ireland and Italy at the Spotless Group, a private equity backed FMCG business, where he assisted in completing a trade exit to Henkel. Prior to this, Mr Luther was Finance Director for the Italian operations of Aptuit, a global healthcare contract services organisation. Prior to Aptuit, David spent 15 years at GlaxoSmithKline (GSK), where he held a number of senior roles. These included Director, Corporate Development, responsible for M&A transactions, Finance Director Neurosciences R&D, plus several Finance Director roles in international markets.
David trained and qualified as an ACA with KPMG and has a BSc in Biochemistry from the University of Surrey, UK.